Adaptive Biotechnologies Corporation · NASDAQ:ADPT
Bobulsky Susan sold 1,299 Adaptive Biotechnologies Corporation shares (Form 4)
Traded Jul 30, 2026 · Filed Aug 3, 2026
On Jul 30, 2026, Bobulsky Susan (Chief Commercial Officer, MRD) sold 1,299 Adaptive Biotechnologies Corporation shares at US$24.00 for US$31,176 under a trading plan, leaving 399,989 shares. Filed Aug 3, 2026 (Form 4).
- Sold
- 1,299 shares
- Price
- US$24.00
- Value
- US$31,176
- Holding after
- 399,989 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Commercial Officer, MRD
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 30, 2026 | Common Stock | Sale | 1,299 | US$24.00 | 399,989 | Direct |
Source
Related
- Adaptive Biotechnologies Corporation
- Bobulsky Susan
- Adaptive Biotechnologies Corporation shareholders
- Form 4 · Bobulsky Susan · Oct 8, 2026
- Form 4 · Bobulsky Susan · Sep 17, 2026
- Form 4 · Bobulsky Susan · Aug 12, 2026
- Form 4 · Bobulsky Susan · Jul 20, 2026
- Form 4 · Bobulsky Susan · Jul 6, 2026
- Form 4 · Rubinstein Julie · Oct 21, 2026
- Form 4 · Rubinstein Julie · Oct 16, 2026
- Form 4 · Rubinstein Julie · Oct 13, 2026
- Form 4 · Rubinstein Julie · Oct 8, 2026
- Form 4 · Rubinstein Julie · Oct 5, 2026